The insulin-like growth factor binding proteins 3 and 7 are associated with colorectal cancer and liver metastasis

Cancer Biology and Therapy

Volumn 12, Issue 1, 2011, Pages 69-79

  Georges, Rania B ^a,b   Adwan, Hassan ^a   Hamdi, Hadjar ^a   Hielscher, Thomas ^a   Linnemann, Ulrich ^c   Berger, Martin R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b AL BAATH UNIVERSITY   (Syrian Arab Republic)

^c Municipal Hospital Nurnberg Nord   (Germany)

Author keywords

IGFBPs; Metastasis formation; Multi functional genes; siRNA silencing; Tumor cell re isolation

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN SW480; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; LIVER METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; UPREGULATION;

AGED; ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RATS; UP-REGULATION;

EID: 79959917001     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.1.15719     Document Type: Article

References (54)

1. WHOSIS. The global burden of disease Geneva: World Health Organization 2008.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
3. Pechlivanis S, Pardini B, Bermejo JL, Wagner K, Naccarati A, Vodickova L, et al. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect. Endocr Relat Cancer 2007; 14:733-40. (Pubitemid 350074062)
4. Park JH. Inhibition of colon cancer cell growth by dietary components: role of the insulin-like growth factor (IGF) system. Asia Pac J Clin Nutr 2008; 17:257-60.
5. de Castro-Carpeno J, Belda-Iniesta C, Casado Saenz E, Hernandez Agudo E, Feliu Batlle J, Gonzalez Baron M. EGFR and colon cancer: a clinical view. Clin Transl Oncol 2008; 10:6-13.
6. Padua D, Massague J. Roles of TGFbeta in metastasis. Cell Res 2009; 19:89-102.
7. Stewart CE, Rotwein P. Growth, differentiation and survival: multiple physiological functions for insulinlike growth factors. Physiol Rev 1996; 76:1005-26. (Pubitemid 26346814)
8. Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 2001; 7:447-54. (Pubitemid 32964159)
9. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000; 183:1-9. (Pubitemid 30130219)
10. Baxter RC, Binoux MA, Clemmons DR, Conover CA, Drop SL, Holly JM, et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab 1998; 83:3213. (Pubitemid 28500960)
11. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20:761-87. (Pubitemid 30648894)
12. Kostecka Y, Blahovec J. Insulin-like growth factor binding proteins and their functions (minireview). Endocr Regul 1999; 33:90-4.
13. Peterkofsky B, Gosiewska A, Wilson S, Kim YR. Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties. Arch Biochem Biophys 1998; 357:101-10. (Pubitemid 28402590)
14. Lee KW, Cohen P. Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3. J Endocrinol 2002; 175:33-40. (Pubitemid 35276584)
15. Baxter RC. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 2001; 54:145-8. (Pubitemid 32539604)
16. Kansra S, Ewton DZ, Wang J, Friedman E. IGFBP-3 mediates TGFbeta1 proliferative response in colon cancer cells. Int J Cancer 2000; 87:373-8. (Pubitemid 30451648)
17. Nam TJ, Busby W Jr, Clemmons DR. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. Endocrinology 1997; 138:2972-8. (Pubitemid 27258531)
18. Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, et al. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 2010; 31:342-9.
19. Ruan WJ, Lin J, Xu EP, Xu FY, Ma Y, Deng H, et al. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B 2006; 7:929-32.
20. Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S, et al. Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity. Biochem Biophys Res Commun 2003; 310:612-8. (Pubitemid 37163708)
21. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377:646-9.
22. Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, et al. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype and p53. Neoplasia 2007; 9:1091-8. (Pubitemid 350255357)
23. Winesett DE, Ulshen MH, Hoyt EC, Mohapatra NK, Fuller CR, Lund PK. Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status. Am J Physiol 1995; 268:631-40.
24. Gill ZP, Perks CM, Newcomb PV, Holly JM. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 1997; 272:25602-7. (Pubitemid 27438873)
25. Hong J, Zhang G, Dong F, Rechler MM. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002; 277:10489-97. (Pubitemid 34968171)
26. Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, et al. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 2000; 60:22-7. (Pubitemid 30058723)
27. Kirman I, Poltoratskaia N, Sylla P, Whelan RL. Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery 2004; 136:205-9. (Pubitemid 39037655)
28. Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, et al. CpG island methylation, response to combination chemotherapy and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 2007; 450:529-37. (Pubitemid 46676250)
29. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3 and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002; 50:642-6. (Pubitemid 34407490)
30. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2004; 13:1444-51. (Pubitemid 39202310)
31. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Insulin-like growth factor I (IGF-I), IGF-binding proteins and breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11:1566-73. (Pubitemid 36020008)
32. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002; 94:1099-106. (Pubitemid 34830730)
33. Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis 2005; 20:203-20. (Pubitemid 40552999)
34. Serel TA, Kecelioglu M. Serum insulin-like growth factor is not a useful marker of prostate cancer. BJU Int 2000; 85:559-60. (Pubitemid 30142643)
35. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92:1592-600.
36. Leal SM, Liu Q, Huang SS, Huang JS. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 1997; 272:20572-6. (Pubitemid 27355615)
37. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000; 275:33607-13.
38. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993; 4:715-22.
39. How HK, Yeoh A, Quah TC, Oh Y, Rosenfeld RG, Lee KO. Insulin-like growth factor binding proteins (IGFBPs) and IGFBP-related protein 1-levels in cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1999; 84:1283-7. (Pubitemid 30644390)
40. Komatsu S, Okazaki Y, Tateno M, Kawai J, Konno H, Kusakabe M, et al. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 2000; 267:109-17. (Pubitemid 30072516)
41. Kato MV. A secreted tumor-suppressor, mac25, with activin-binding activity. Mol Med 2000; 6:126-35.
42. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002; 13:205-13. (Pubitemid 34651181)
43. Ruan W, Wang Y, Ma Y, Xing X, Lin J, Cui J, et al. HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma. J Exp Clin Cancer Res 29:41.
44. Adachi Y, Itoh F, Yamamoto H, Arimura Y, Kikkawa-Okabe Y, Miyazaki K, et al. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 2001; 95:216-22. (Pubitemid 32592087)
45. Shao L, Huang Q, Luo M, Lai M. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer 2004; 11:141-8. (Pubitemid 38419729)
46. Ma Y, Lu B, Ruan W, Wang H, Lin J, Hu H, et al. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Exp Mol Pathol 2008; 85:141-5.
47. Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 2002; 175:19-31. (Pubitemid 35276583)
48. Jiang W, Xiang C, Cazacu S, Brodie C, Mikkelsen T. Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration. Neoplasia 2008; 10:1335-42.
49. Leibowitz BJ, Cohick WS. Endogenous IGFBP-3 is required for both growth factor-stimulated cell proliferation and cytokine-induced apoptosis in mammary epithelial cells. J Cell Physiol 2009; 220:182-8.
50. Cohen P, Rajah R, Rosenbloom J, Herrick DJ. IGFBP-3 mediates TGFbeta1-induced cell growth in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 278:545-51.
51. Janssen HCJP, Samson MM, Verhaar HJJ. Vitamin D deficiency, muscle function and falls in elderly people. Am J Clin Nutr 2002; 75:611-5. (Pubitemid 34250675)
52. Bikle DD. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev 1992; 13:765-84. (Pubitemid 23037214)
53. Adwan H, Bauerle TJ, Berger MR. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 2004; 11:109-20. (Pubitemid 38141773)
54. Georges R, Adwan H, Zhivkova M, Eyol E, Bergmann F, Berger MR. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells. Int J Oncol 2010; 37:249-56.